|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Washington University School of Medicine |
| Information provided by: | Office of Rare Diseases (ORD) |
| ClinicalTrials.gov Identifier: | NCT00004348 |
Purpose
OBJECTIVES:
I. Characterize inheritance patterns of mutations in patients with beta-oxidation disorders.
| Condition |
|
Beta-Oxidation Disorder Peroxisomal Disorders |
| Genetics Home Reference related topics: | beta-ketothiolase deficiency |
| Study Type: | Observational |
| Study Design: | Screening |
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
PROTOCOL ENTRY CRITERIA:
Beta-oxidation disorder, including: Medium-chain acyl-coenzyme A dehydrogenase deficiency Long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency Very-long-chain acyl-coenzyme A dehydrogenase deficiency Short-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency Long-chain 3-ketoacyl-coenzyme A thiolase deficiency Trifunctional protein deficiency Patient age: 1 day and over
Contacts and Locations| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Washington University School of Medicine |
| Study Chair: | Arnold W. Strauss | Washington University School of Medicine |
More Information
| Study ID Numbers: | 199/11907, WUSM-880075R |
| First Received: | October 18, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00004348 |
| Health Authority: | United States: Federal Government |
|
|
|
|